BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

CDK4

MOLECULAR TARGET

cyclin dependent kinase 4

UniProt: P11802NCBI Gene: 1019160 compounds

CDK4 (cyclin dependent kinase 4) is targeted by 160 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CDK4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1seliciclib4.91135
2alvocidib4.5291
3palbociclib4.2267
4ceritinib4.1965
5bi 25364.0154
6dinaciclib3.8747
7abemaciclib3.6638
8nintedanib3.6136
9bms 3870323.4731
10tae 6843.4330
11fedratinib3.4029
12gilteritinib3.4029
13at 75193.3327
14dabrafenib3.3026
15ribociclib3.2625
16purvalanola3.1823
17sulfuretin3.1422
18dovitinib3.0921
19at 92833.0921
20lestaurtinib3.0420
21ruboxistaurin2.9418
22k 252a2.8316
23su 95162.8316
24milciclib2.7715
25pha 6657522.7114
26azd 54382.7114
27kw 24492.6413
28fascaplysin chloride2.6413
29ast 4872.5612
30roniciclib2.5612
31su 0148132.208
32rebastinib2.208
33encorafenib2.208
34ct 70012.208
35cyc 1162.087
36rg 5472.087
37zemirciclib2.087
38ebvaciclib2.087
39gw779439x2.087
40voruciclib1.795
41ly 20903141.795
42bdb 5s 6r 7r 9r 16r 16 hydroxy 6 methoxy 5 methyl 7 methylamino 6 7 8 9 15 16 hexahy1.393
43achyranthes bidentata1.001
44agastache rugosa1.001
45Garlic1.001
46aloe vera1.001
47anemarrhena asphodeloides1.001
48arctium lappa1.001
49artemisia annua1.001
50artemisia argyi1.001

Showing top 50 of 160 compounds. Use the BiohacksAI search to explore all CDK4 modulators.

About CDK4 as a Drug Target

CDK4 (cyclin dependent kinase 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 160 compounds with documented CDK4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CDK4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.